122310 — Genoray Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMicro CapNeutral

Annual income statement for Genoray Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	74,290	82,604	97,897	106,982	108,042
Cost of Revenue
Gross Profit	30,992	35,261	37,544	39,536	41,653
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	59,323	67,686	85,140	114,491	108,285
Operating Profit	14,968	14,918	12,757	-7,510	-243
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	15,787	15,704	12,961	-5,988	-1,133
Provision for Income Taxes
Net Income After Taxes	14,323	13,900	12,356	-2,537	628
Minority Interest
Net Income Before Extraordinary Items
Net Income	14,323	13,900	12,486	-1,797	758
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	14,323	13,900	12,486	-1,797	758
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	999	987	911	525	56.5
Dividends per Share